Neumora Therapeutics NMRA
NASDAQ NMRA
$0.41 -0.01 (-2.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Net Debt Issuances and Repayments (2025)

Updated

Analysis

Neumora Therapeutics (NMRA) Net Debt Issuances and Repayments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 64.00 Mn
10 Neumora Therapeutics 73.19 Mn -544.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 38.90 Mn
Sep 30, 2025 -136,000.00
API Access

Neumora Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=NMRA&period=max&api_key=YOUR_API_KEY